Lixisenatide Significantly Reduces Blood Sugar Levels Without Increasing Hypoglycaemia In Patients With Uncontrolled Type 2 Diabetes On Sulfonylureas
Links shared publicly online about this topic.
- 362total visits
Lixisenatide Significantly Reduces Blood Sugar Levels Without Increasing Hypoglycaemia In Patients With Uncontrolled Type 2 Diabetes On Sulfonylureas
Sanofi-aventis announced on Wednesday that lixisenatide, a once-daily GLP-1 receptor agonist under development for people with Type 2 diabetes, achieved its primary efficacy objective of significa
View full resource at medicalnewstoday.com
Tags: Diabetes, Blood Sugar, Type 2 Diabetes, Sanofi-Aventis
Most Recently Shared on April 15, 2011 at 10:23 pm By:
Lixisenatide Significantly Reduces Blood Sugar Levels Without Increasing Hypoglycaemia In Patients With Uncontro... http://bit.ly/gsn7My
Lixisenatide Significantly Reduces Blood Sugar Levels Without Increasing Hypoglycaemia In Patients With Uncontrolled Type 2 Diabetes On Sulfonylureas
medicalnewstoday.com — “Sanofi-aventis announced on Wednesday that lixisenatide, a once-daily GLP-1 receptor agonist under development for people with Type 2 diabetes, achieved its primary efficacy objective of significa” View full resource at medicalnewstoday.com
Most Recently Shared on April 15, 2011 at 8:26 pm By:
Endocrinology Wisdom OW Health
Lixisenatide Significantly Reduces Blood Sugar Levels Without Increasing Hypoglycaemia In Patients With Uncontro... http://bit.ly/fAoMVL
Advertisement
